My Portfolio
+
LINK YOUR PORTFOLIO

Ironwood Pharmaceuticals Inc IRWD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:41 PM EDT
3.20quote price arrow down-0.04 (-1.23%)
Volume
45,138
Close
3.24quote price arrow down-0.04 (-1.22%)
Volume
2,620,709
52 week range
0.56 - 5.78
Loading...
  • Open3.30
  • Day High3.30
  • Day Low3.19
  • Prev Close3.28
  • 52 Week High5.78
  • 52 Week High Date01/02/26
  • 52 Week Low0.56
  • 52 Week Low Date06/05/25

Latest On Ironwood Pharmaceuticals Inc

 

Key Stats

  • Market Cap533.347M
  • Shares Out164.61M
  • 10 Day Average Volume2.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.24

Latest On Ironwood Pharmaceuticals Inc

 

KEY STATS

  • Open3.30
  • Day High3.30
  • Day Low3.19
  • Prev Close3.28
  • 52 Week High5.78
  • 52 Week High Date01/02/26
  • 52 Week Low0.56
  • 52 Week Low Date06/05/25
  • Market Cap533.347M
  • Shares Out164.61M
  • 10 Day Average Volume2.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.24

RATIOS/PROFITABILITY

  • EPS (TTM)0.58
  • P/E (TTM)5.54
  • Fwd P/E (NTM)2.87
  • EBITDA (TTM)203.686M
  • ROE (TTM)-559.14%
  • Revenue (TTM)361.514M
  • Gross Margin (TTM)27.85%
  • Net Margin (TTM)28.26%
  • Debt To Equity (MRQ)-269.34%

EVENTS

  • Earnings Date08/05/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Ironwood Pharmaceuticals, Inc. is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI), and rare diseases. It is focused on the development and commercialization of GI product opportunities in areas of significant unmet need. LINZESS (linaclotide), its commercial product, is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic...
Julie Mchugh
Independent Chairman of the Board
Thomas Mccourt
Chief Executive Officer, Director
Ronald Silver
Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller
Address
100 Summer Street, Suite 2300
Boston, MA
02110
United States